Awareness about and willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among people who use drugs

In the Bangkok Tenofovir Study of oral pre-exposure prophylaxis (PrEP; TDF/FTC), adherence was poor. Long-acting injectable pre-exposure prophylaxis (LAI-PrEP) for HIV prevention may help overcome adherence challenges and is currently being tested in clinical trials, but not in people who use drugs...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Subst Abuse Treat
Main Authors: Shrestha, Roman, DiDomizio, Elizabeth E., Kim, Rayne S., Altice, Frederick L., Wickersham, Jeffrey A., Copenhaver, Michael M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7438607/
https://ncbi.nlm.nih.gov/pubmed/32811633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsat.2020.108058
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados